BiomX Inc.
PHGE · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.01 | -0.01 | 0.01 |
| FCF Yield | -43.69% | -43.36% | -67.85% | -12.36% |
| EV / EBITDA | -1.65 | -1.65 | -0.27 | -5.63 |
| Quality | ||||
| ROIC | -38.38% | -22.51% | -19.50% | 46.22% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.78 | 1.01 | 1.14 | 0.43 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | -17.61% | 29.88% | -38.29% | 22.29% |
| Safety | ||||
| Net Debt / EBITDA | 0.14 | 0.82 | 1.46 | 1.08 |
| Interest Coverage | -1,707.20 | -247.77 | -9.58 | 3,337.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -671.30 | 0.00 | 0.00 |